Koss Olinger Consulting LLC reduced its position in Corteva, Inc. (NYSE:CTVA – Free Report) by 22.8% in the fourth quarter, Holdings Channel.com reports. The firm owned 24,462 shares of the company’s stock after selling 7,210 shares during the quarter. Koss Olinger Consulting LLC’s holdings in Corteva were worth $1,640,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Activest Wealth Management boosted its holdings in shares of Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares in the last quarter. JPL Wealth Management LLC purchased a new position in shares of Corteva in the 3rd quarter worth about $25,000. Redmont Wealth Advisors LLC purchased a new position in shares of Corteva in the 3rd quarter worth about $29,000. Basepoint Wealth LLC purchased a new position in shares of Corteva in the 4th quarter worth about $30,000. Finally, Jackson Grant Investment Advisers Inc. boosted its holdings in shares of Corteva by 90.6% in the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after purchasing an additional 213 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
CTVA has been the subject of several analyst reports. Berenberg Bank increased their target price on Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a report on Thursday, March 26th. Citigroup increased their target price on Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Royal Bank Of Canada increased their target price on Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Rothschild & Co Redburn increased their target price on Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Finally, Wolfe Research increased their target price on Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Fourteen research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $88.67.
Corteva Trading Down 2.7%
NYSE CTVA opened at $78.41 on Friday. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The stock has a 50 day simple moving average of $81.33 and a two-hundred day simple moving average of $74.53. The stock has a market cap of $52.44 billion, a P/E ratio of 46.12, a price-to-earnings-growth ratio of 2.47 and a beta of 0.59.
Corteva (NYSE:CTVA – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The business had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter last year, the business posted $1.13 EPS. The business’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.
Corteva Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be issued a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 42.35%.
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Further Reading
- Five stocks we like better than Corteva
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
